Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
44.25 GBX | -0.56% | -1.67% | -18.06% |
May. 08 | EARNINGS: International Biotechnology bullish; Andrews Sykes profit up | AN |
May. 08 | The Brighton Pier Group PLC Reports Earnings Results for the Full Year Ended December 24, 2023 | CI |
Sales 2024 * | 35.1M 44.78M | Sales 2025 * | - | Capitalization | 16.59M 21.17M |
---|---|---|---|---|---|
Net income 2024 * | 4M 5.1M | Net income 2025 * | - | EV / Sales 2024 * | 0.66 x |
Net Debt 2024 * | 6.7M 8.55M | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
3.87
x | P/E ratio 2025 * |
-
| Employees | 681 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 35.94% |
1 day | -5.17% | ||
1 week | -6.22% | ||
Current month | -2.99% | ||
1 month | -5.17% | ||
3 months | -23.27% | ||
6 months | +25.97% | ||
Current year | -21.85% |
Managers | Title | Age | Since |
---|---|---|---|
Anne Ackord
CEO | Chief Executive Officer | - | 17-03-31 |
John Smith
DFI | Director of Finance/CFO | 65 | 06-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Luke Johnson
CHM | Chairman | 62 | 15-06-14 |
Paul Viner
BRD | Director/Board Member | 54 | 15-07-29 |
John Smith
DFI | Director of Finance/CFO | 65 | 06-05-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-29 | 44.25 | -0.56% | 25 066 |
24-05-28 | 44.5 | 0.00% | 1,651 |
24-05-24 | 44.5 | -1.11% | 14,699 |
24-05-23 | 45 | 0.00% | 3,957 |
24-05-22 | 45 | 0.00% | 11,869 |
Delayed Quote London S.E., May 29, 2024 at 04:00 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.85% | 21.2M | |
-16.82% | 47.16B | |
-5.22% | 3.13B | |
+10.08% | 2.25B | |
+4.90% | 2.22B | |
+21.11% | 1.17B | |
-18.95% | 800M | |
+1.70% | 598M | |
+0.96% | 579M | |
+7.12% | 374M |
- Stock Market
- Equities
- PIER Stock